Research direction, process innovation, and new product approvals.

Swift's Center for Innovations supports formulation development, product transfer, testing, and patent-backed pharmaceutical process improvement.

Center for Innovations

Swift is building expertise in pharmaceutical research as part of its mission to become a Center for Innovations.

The team focuses on formulation development, testing, manufacturing safety, product transfer support, and process improvement for a changing healthcare industry.

Patent
IN551347 — Single Pot DRC Technology

Proprietary process innovation developed by Swift Life Sciences in pharmaceutical manufacturing methodology.

Swift Life Sciences manufacturing facility

Approved product and upcoming pipeline.

A focused view of current approval status and pipeline movement from SWIFT's innovation direction.

DCGI Approved Patented Technology Dextromethorphan Hydrobromide & Chloropheniramine Maleate Sustained Release Suspension

Approved combination product for cough and cold therapy category. Commercial details can be updated as launch planning progresses.

Pipeline 10+ products under review

Additional formulations are in the approval pipeline and will be added once regulatory clearance is received.